All posts
14550 total · page 30 of 291
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has divested a 9.9% stake in Thyrocare Technologies, selling shares worth Rs 986 crore through stock exchanges.
Surrogate Birth Sparks Legal Battle Over Baby's Custody
A surrogate's decision to carry a baby to term despite biological parents' wishes has led to a custody dispute.
Medical Device Firms Reject Draft Bill Equating Them with Pharma
India's medical device industry opposes a draft bill treating devices like drugs, fearing impacts on innovation and investment.
Abhay Soi Challenges Hospital Room Price Caps Amid Expansion Talks
Max Healthcare's Abhay Soi questions proposed room rent caps, citing investment needs.
Molbio Diagnostics Eyes ₹940 Crore Through IPO to Fuel Expansion
Molbio Diagnostics plans an IPO to raise ₹940 crore, aiming to boost capital expenditure and reduce promoter stake while expanding its global reach.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has reduced its stake in Thyrocare Technologies by 9.9%, generating Rs 986 crore through bulk and block deals.
Surrogate Birth Sparks Legal Battle Over Baby's Custody
A surrogate mother is contesting custody after giving birth to a baby with a heart defect amid a legal dispute with the biological parents.
Industry Pushback: Draft Bill Misclassifies Medical Devices as Pharma
Medical device sector challenges 2026 draft bill, warns it could stifle innovation with pharma-style regulations.
Abhay Soi Challenges Price Caps on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against price caps on hospital rooms, citing investment needs.
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Global Expansion
Molbio Diagnostics seeks ₹940 crore via IPO to fund expansion and reduce promoter stake, with a focus on its Truenat platform.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests nearly 10% of Thyrocare, attracting major institutional investors.
Surrogate Birth Sparks Legal Battle Over Child Custody
A surrogate birth in Texas has led to a legal fight as the surrogate seeks custody after parents requested termination due to a heart defect.
Medical Device Industry Opposes Draft Bill Over Pharma Regulations
India's medical device sector challenges a draft bill equating devices with drugs, citing risks to innovation and investment.
Abhay Soi Criticizes Proposed Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against a proposed price cap on private hospital rooms, citing investment concerns.
Molbio Diagnostics Eyes ₹940 Crore in IPO for Expansion and Stake Sale
Molbio Diagnostics plans to raise ₹940 crore through IPO to fund expansion and reduce promoter stake. The company targets high-risk investors.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests 9.9% stake in Thyrocare Technologies, raising Rs 986 crore through bulk and block deals on NSE and BSE.
Surrogate Birth Sparks Legal Battle Over Child Custody
A surrogate birth has ignited a legal battle after biological parents sought termination. The surrogate fled to Texas, giving birth amidst the dispute.
Medical Device Industry Challenges Draft Regulation Bill in India
Industry groups argue draft bill threatens innovation by equating devices with drugs.
Abhay Soi Challenges Proposed Cap on Private Hospital Room Rates
Max Healthcare's Abhay Soi argues against a blanket cap on private hospital room rates, stressing investment needs.
Molbio Diagnostics IPO: Potential Long-Term Growth for Risk-Takers
Molbio Diagnostics seeks ₹200 crore for expansion, with plans to reduce promoter stake by ₹740 crore. The company shows promising growth despite customer concentration.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has reduced its holding in Thyrocare by selling a 9.9% stake, fetching Rs 986 crore.
Surrogate Birth Sparks Legal Battle Over Custody
A surrogate who defied biological parents' request to terminate a pregnancy now seeks custody of the newborn.
Draft Bill Sparks Opposition from India's Medical Device Industry
Medical device firms oppose a draft bill treating devices like drugs, citing risks to innovation and manufacturing.
Abhay Soi Challenges Proposed Price Cap on Private Hospitals
Abhay Soi argues against a blanket price cap on private hospital room rents, emphasizing investment needs.
SCTIMST Launches Chitra Core: A New Era in Coronary Stents
SCTIMST introduces Chitra Core, its inaugural coronary stent, promising advancements in cardiac care.
Russian Scientists Innovate Coatings to Enhance Orthopaedic Implants
New coatings developed by Russian researchers aim to improve the integration of orthopaedic implants, potentially boosting patient outcomes.
Revolutionary Kidney Implant Eliminates Needle Pricks in Dialysis
A novel kidney implant offers needle-free dialysis, transforming treatment for patients.
Study Compares Implant Overdenture Attachment Systems
Research evaluates retention, bite force, and satisfaction in implant overdentures.
Molbio Diagnostics Targets ₹940 Crore in IPO to Fuel Expansion
Molbio Diagnostics seeks ₹940 crore via IPO for growth and reducing promoter stake. High-risk investors eye potential in global diagnostics market.
Docon Sells 9.9% Thyrocare Stake for Rs 986 Crore
Docon Technologies divests nearly 10% of Thyrocare, raising Rs 986 crore through bulk and block deals.
Unveiling Hidden Chemicals in Plastics and Ways to Avoid Them
Explore the hidden chemicals in everyday plastics and learn effective strategies to minimize exposure.
Common Food Ingredient May Worsen Arthritis Symptoms
Research highlights how certain everyday foods can exacerbate arthritis symptoms.
Surrogate Birth Sparks Legal Battle Over Child Custody
A surrogate's decision to give birth in Texas amid a legal dispute with biological parents has intensified the custody battle.
Medical Device Sector Challenges Draft Bill's Pharma Parallels
India's medical device sector opposes the 2026 draft bill, citing concerns on innovation and investment due to pharma-like regulations.
Abhay Soi Challenges Proposed Price Caps on Private Hospitals
Abhay Soi emphasizes investment needs in response to suggested room rate caps for private hospitals.
Molbio Diagnostics Eyes ₹200 Crore IPO for Expansion Amidst Investor Scrutiny
Molbio Diagnostics plans a ₹200 crore IPO to fund expansion and reduce promoter stake, targeting high-risk investors.
Docon Sells 9.9% Thyrocare Stake for Rs 986 Crore
Docon Technologies divests nearly 10% of Thyrocare, raising Rs 986 crore through NSE and BSE transactions.
Surrogate Birth Triggers Legal Battle Over Child Custody
A surrogate mother is challenging the biological parents for custody after giving birth to a baby diagnosed with a heart defect.
Medical Device Firms Oppose Draft Bill Equating Devices with Drugs
India's medical device industry is challenging a draft bill that treats devices like drugs, fearing it may stifle innovation and investment.
Max Healthcare's Abhay Soi Challenges Proposed Hospital Price Caps
Max Healthcare's Abhay Soi argues against a blanket price cap on hospital room rents, citing investment concerns.
Molbio Diagnostics Plans ₹200 Crore IPO Amid Global Expansion
Molbio Diagnostics seeks to raise ₹200 crore for capital expenditures and reduce promoter stake via a ₹740 crore offer for sale.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has reduced its stake in Thyrocare Technologies by 9.9%, raising Rs 986 crore through stock exchanges.
Surrogate Birth Sparks Legal Battle Over Custody in Texas
A surrogate is contesting custody after giving birth in Texas, following a request from the biological parents to terminate the pregnancy.
Medical Device Firms Oppose Draft Bill Treating Them Like Pharma
India's medical device sector challenges a draft bill that equates devices with pharmaceuticals, fearing it will stifle innovation and investment.
Max Healthcare's Abhay Soi Criticizes Proposed Hospital Price Caps
Abhay Soi argues against a blanket cap on private hospital room rents, emphasizing investment needs.
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Expansion
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake. Revenue growth driven by TB test kits.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has reduced its stake in Thyrocare Technologies by 9.9%, raising Rs 986 crore through bulk and block deals on NSE and BSE.
Surrogate Birth Sparks Legal Battle with Biological Parents
A surrogate mother is locked in a legal fight after giving birth to a baby with a heart defect, defying the biological parents' request for termination.
Industry Pushback: Medical Devices Not Pharmaceuticals, Say Companies
India's medical device sector opposes a draft bill treating devices like drugs, fearing it will stifle innovation and investment.
Abhay Soi Challenges Proposed Price Cap on Private Hospital Rooms
Abhay Soi argues against a one-size-fits-all price cap on hospital room rents, citing investment needs.